
Vol. 25, No. 1, 2007
Free Abstract
Article (References)
Article (PDF 114 KB)
Paper
What Is Needed to Achieve a Hemoglobin of 11.0-13.0 g/dl in End-Stage Renal Disease
Steven Fishbane
Winthrop-University Hospital, Mineola, N.Y., USA
Address of Corresponding Author
Blood Purif 2007;25:53-57 (DOI: 10.1159/000096398)
Key Words
- End-stage renal disease
- Hemoglobin
- Anemia
Abstract
Effective treatment of anemia in end-stage renal disease (ESRD) results in reduced fatigue and improved quality of life. The National Kidney Foundation's 2006 anemia treatment guidelines recommend maintaining hemoglobin (Hb) at >11 g/dl, while noting that there is insufficient evidence to routinely maintain Hb levels 13.0 g/dl. Success in achieving Hb levels within these targets requires careful monitoring and adjustments to treatment. In addition, causes for diminished response and refractory anemia must be adequately evaluated. In this article, factors important for achieving Hb 11-13 g/dl in patients with ESRD are reviewed. Copyright © 2007 S. Karger AG, Basel
Author Contacts Steven Fishbane, MD Winthrop-University Hospital 200 Old Country Road Suite 135 Mineola, NY 11501 (USA) Tel. +1 516 663 2169, Fax +1 516 663 2179, E-Mail sfishbane@winthrop.org
Article Information
Published online: December 14, 2006
Number of Print Pages : 5
Number of Figures : 0, Number of Tables : 0, Number of References : 26 |
|

|

For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service. |
|
|